Persistent Asset Partners »

Nurix Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $751k 31k 24.26

More positions owned by Persistent Asset Partners

Intel Corporation Call Option (INTC)
Kla Corp Com New Call Option (KLAC)
Nebius Group Shs Class A Call Option (NBIS)
Kodiak Sciences Call Option (KOD)
Novo-nordisk A S Adr Put Option (NVO)
Corning Incorporated Call Option (GLW)
Vaxcyte Call Option (PCVX)
Micron Technology Call Option (MU)
Monte Rosa Therapeutics Call Option (GLUE)
Robinhood Mkts Com Cl A (HOOD)
Arcus Biosciences Incorporated Call Option (RCUS)
Stmicroelectronics N V Ny Registry (STM)
Uniqure Nv SHS Call Option (QURE)
Amphenol Corp Cl A (APH)
Marvell Technology Call Option (MRVL)

View all positions for Persistent Asset Partners

Top funds holding Nurix Therapeutics

BlackRock
Vestal Point Capital
Deep Track Capital
Rubric Capital Management
FMR
State Street Corporation
Morgan Stanley
Baker Bros. Advisors
Vanguard Capital Management
Perceptive Advisors
Redmile Group
T. Rowe Price Associates
General Atlantic
Geode Capital Management
Pictet Asset Management Holding SA

View all funds holding Nurix Therapeutics